Application of 1,8-naphthyridinyl fluorescent molecular probe in research on neural mechanism of ketamine recreational abuse and diagnosis of addiction degree
A fluorescent probe, ketamine technology, applied in the field of biomedicine, to achieve the effect that is difficult to promote and expensive
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] The preparation of embodiment 1, C3 compound
[0058] according to figure 2 The synthetic scheme shown prepares the C3 compound.
[0059] step 1:
[0060] Synthesis of 2-amino-5,7-trifluoromethyl-1,8-naphthyridine (compound 1): 2,6-diaminopyridine (commercially available, analytically pure, 10.9g, 0.1mol) and hexafluoroacetyl Acetone (commercially available, analytically pure, 10.0 g, 0.1 mol), 100 mL of phosphoric acid, under nitrogen protection, stirred and refluxed for 24 hours. The reaction solution was cooled, and adjusted to neutrality with ammonia water under ice bath conditions. Refrigerate overnight at 5°C, then filter with suction, wash the filter cake with cold water, and dry to obtain the crude product. The crude product was recrystallized from absolute ethanol to obtain light yellow solid powder. Yield: 17.3g (61.3%).
[0061] Step 2:
[0062] Synthesis of Compound 3: Compound 1 (2.81 g, 0.01 mol) and Compound 2 (0.01 mol) were dissolved in 100 mL o...
Embodiment 2
[0069] Example 2. Application of C3 compound in research on neural mechanism of recreational abuse of ketamine and diagnosis of addiction degree
[0070] Ketamine Abuse SD Rat Model:
[0071] 1. One administration mode and two different dosages were studied in SD rats with administration time of 1 month:
[0072] Model 1: Select 9 healthy Kunming SD rats (male, 6 months old) and inject ketamine intraperitoneally at a dose of (30 mg / kg) for biochemical detection. Body weight was measured weekly and doses were adjusted.
[0073] Model 2: Select 9 healthy Kunming SD rats (male, 6 months old) and inject ketamine intraperitoneally at a dose of (60 mg / kg) for biochemical detection. Body weight was measured weekly and doses were adjusted.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


